Cheung R (2014) The Utility of a Robotic Stereotactic Radiation Treatment System to Treat Primary and Metastatic Liver Tumors. Austin J Cancer Clin Res 1: 2.

Cheung R (2014) Using a Robotic Stereotactic Radiation Treatment System to Treat Benign Intracranial Tumors and Trigeminal Neuralgia. Austin J Radiat Oncol & Cancer 1: 

Cheung MR (2014) Receiver Operating Characteristic Curve Analysis of SEER Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) Outcome Data: Identification and Optimization of Predictive Models. Asian Pac J Cancer Prev 15: 6781-6785.

Cheung MR (2014) Under-use of radiotherapy in stage III bronchioaveolar lung cancer and socio-economic disparities in cause specific survival: a population study. Asian Pac J Cancer Prev 15: 4091-4094. 

Cheung MR (2014) Optimization of predictors of Ewing sarcoma cause-specific survival: a population study. Asian Pac J Cancer Prev 15: 4143-4145.

Katz, A. and Kang, J. (2014) Stereotactic Body Radiotherapy as Treatment for Organ Confined Low and Intermediate Risk Prostate Carcinoma: a Seven Year Study. Frontiers in Oncology.4:240

 Kang, J., Ouyang, D., Katz, A. and Yeung, V. “Unresectable pancreatic adenocarcinoma: local control and palliation after stereotactic radiation treatment.” Poster presentation at CAMS 50th Annual Scientific Meeting, New York, NY, 2013.

Kang, J., Ouyang, D., Li, David and Yeung, V. “Stereotactic body radiation therapy for hepatic tumors: analysis of outcomes.” Oral presentation at CAMS 50th Annual Scientific Meeting, New York, NY, 2013.

Katz, A. and Kang, J. “Stereotactic body radiotherapy for low, intermediate and high-risk organ confined prostate cancer at 7 years: control, toxicity and quality of life.” Poster presentation at American Radium Society 2014 Meeting in St. Thomas, V.I.; award for outstanding poster.

Katz, A. and Kang, J. “Stereotactic body radiotherapy with and without EBRT for organ confined high-risk prostate cancer.”  Oral presentation at American Radium Society 2014 Meeting in St. Thomas, V.I.

Katz, A. and Kang, J. “Stereotactic body radiotherapy as treatment for organ confined high-risk prostate carcinoma.”  Poster presentation at 2014 Radiosurgery Society Meeting in MN.

Katz, A. and Kang, J. “Stereotactic body radiotherapy with and without EBRT for organ confined high-risk prostate cancer.” Poster presentation at 2014 20th Annual DEGRO meeting in Germany.

Kang, J., Mahadevan, A. “Stereotactic body radiotherapy for metastatic melanoma”. Poster presentation at 2013 Radiosurgery Society Meeting, Carlsbad, CA, 2013.

Katz, A. and Kang, J. “Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: disease control and quality of life at five years.” Oral presentation at 55thAnnual Meeting of ASTRO, Atlanta, GA,

2013.Li, D., Kang, J. and Madoff, D. (2014) Review: Ablative approaches to treatment of hepatic tumors. Expert Review of Anticancer Therapy. 1-15.

Cheung, R. (2014) Surveying and Optimizing the Predictors for Ependymoma Specific Survival using SEER Data. Asian Pacific Journal of Cancer Prevention. 15(2):867-70.

Katz, A. and Kang, J. (2014) Stereotactic body radiotherapy as treatment for organ confined high-risk prostate carcinoma: A Six Year Study. Radiation Oncology. 9:1

Cheung, R, Kang, J., Ouyang, D. and Yeung, V. (2014) The association between urinary cadmium and all cause, all cancer and prostate cancer specific mortalities for men: an analysis of the National Health and Nutrition Examination Survey (NHANES III) data. Asian Pacific Journal of Cancer Prevention. 15(1):483-8.

Katz and J. Kang. Feature co-editors for Frontiers In Oncology Journal, Feature Topic of “Stereotactic Body Radiotherapy for Early Prostate Cancer: An Emerging New Standard of Care.” To be published in Fall 2014.

Cheung, R, Kang, J., Ouyang, D., and Yeung, V. (2014) Socio-economic factors affect the outcome of soft tissue sarcoma: an analysis of SEER data. Asian Pacific Journal of Cancer Prevention. 15(1): 25-8.

Cheung, R. (2013) Assessing the Impact of Socio-economic Variables on Breast Cancer Treatment Outcome Disparity. Asian Pacific Journal of Cancer Prevention. 14(12):7133-6.

Kang, J. and Viswanathan, A. (2013) Vaginal Cancer. Chapter in: Perez and Brady’s Principles and Practice of Radiation Oncology, 6th Edition. US: Lippincott Williams & Wilkins.

Current online editor of Perez and Brady’s Principles and Practice of Radiation Oncology, 6th Edition (2013), section on Gynecologic Tumors: Cervix, Endometrial, Ovary, Vagina, Female Urethra and Vulva.

Kang, J., Botros, M., Goldberg, S., Giraud, C., Nielsen, G.P., Chen, Y., Raskin, K., Schwab, J., Yoon, S.S., Hornicek, F.J., DeLaney, T.F. (2013) The Use of Radiation Therapy in the Management of Selected Patients with Atypical Lipomas. Sarcoma. 2013:485483.

Kang, J., Mahadevan, A. “Stereotactic body radiotherapy for metastatic melanoma”. Poster presentation at 2013 Radiosurgery Society Meeting, Carlsbad, CA, 2013.

Katz, A. and Kang, J. “Stereotactic body radiation therapy for low-, intermediate- and high-risk prostate cancer: disease control and quality of life at five years.” Oral presentation at 55th Annual Meeting of ASTRO, Atlanta, GA, 2013.

Kang, J., Ouyang, D., Katz, A. and Yeung, V. “Unresectable pancreatic adenocarcinoma: local control and palliation after stereotactic radiation treatment.” Poster presentation at CAMS 50th Annual Scientific Meeting, New York, NY, 2013.

Kang, J., Ouyang, D., Li, David and Yeung, V. “Stereotactic body radiation therapy for hepatic tumors: analysis of outcomes.” Oral presentation at CAMS 50th Annual Scientific Meeting, New York, NY, 2013.

Katz, A.J., Santoro, M., Diblasio, F. and Ashley, R. (2013) Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol. 8(1):118.

Katz, A.J. (2013) CyberKnife radiosurgery for prostate cancer. Technol Cancer Res Treat. 9(5):463-72.

Kang, J., Mahadevan, A.” Outcomes of fractionated stereotactic body radiotherapy in treatment of metastatic melanoma.” Poster presentation at the 54th Annual Meeting of ASTRO, Boston, MA, 2012.

Kang, J., Botros, M., Goldberg, S., Giraud, C., Nielsen, G.P., Chen, Y., Raskin, K., Schwab, J., Yoon, S.S., Hornicek, F.J., DeLaney, T.F. “The use of radiation therapy in the management of selected patients with atypical lipomas”.Poster presentation at the 54th Annual Meeting of ASTRO, Boston, MA, 2012.

Contribute!

LOCATIONS

Flushing: 40-22 Main St, 4th Fl,
Flushing, NY 11354
Brooklyn: 1737 Bath Ave
Brooklyn, NY 11214
Manhattan: 47 Essex St.
New York, NY 10002

STAY CONNECTED

Stay in touch with FROS Radiation Oncology & Cyberknife Centers. Join us on Facebook, Twitter and LinkedIn for latest news and info.